Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Generic Pharmaceuticals Market Growth Potential: How Will Market Size Shift Through 2030?
The generic pharmaceuticals market size has experienced significant expansion in recent years. It is projected to increase from $426.3 billion in 2025 to $453.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. The historic growth in this market can be attributed to factors such as the expiry of patents for major drugs, rising concerns about healthcare expenses, increased understanding and acceptance of generics among patients and doctors, the expansion of hospital and retail pharmacy networks, and the wider adoption of oral and injectable generic formulations.
The generic pharmaceuticals market is projected to experience substantial expansion in the coming years, reaching $588.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is largely driven by factors such as the introduction of complex generics and extended-release formulations, augmented government backing for generics, escalating demand for biosimilars, the expansion of e-pharmacy platforms, and strategic investments in manufacturing automation and digital quality control. Key trends expected during this period involve a growing inclination towards cost-effective generic medications, broadening of generic drug offerings across various therapeutic segments, increased uptake of branded generics and over-the-counter (OTC) generics, the development of online and physical retail pharmacy distribution networks, and a heightened emphasis on regulatory adherence and quality assurance within generic drug production.
Get A Free Sample Report With In-Depth Market Insights:
Generic Pharmaceuticals Market Growth Factors Behind Sustained Expansion
The increasing prevalence of chronic diseases is anticipated to propel the growth of the generic pharmaceuticals market in the coming years. Chronic diseases are long-term medical conditions that usually advance gradually and demand ongoing medical attention, examples being diabetes, cardiovascular diseases, and hypertension. This rise in chronic disease incidence is fueled by elements like aging populations, sedentary lifestyles, and unhealthy dietary habits. Generic pharmaceuticals effectively support the management of chronic diseases by providing cost-effective, widely available, and therapeutically equivalent substitutes for brand-name medications. This contributes to improved long-term treatment adherence, reduces financial strain on patients and healthcare systems, and enhances overall disease control and patient quality of life. For instance, in January 2023, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that in 2023, 76.4% of U.S. adults, approximately 194 million people, stated they had at least one chronic condition, with prevalence rates reaching 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the expanding incidence of chronic diseases is a significant driver for the growth of the generic pharmaceuticals market.
Generic Pharmaceuticals Market Segment Trends And Revenue Contributors
The generic pharmaceuticals market covered in this report is segmented –
1) By Type: Biosimilars, Generics
2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled
3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies
Subsegments:
1) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Other Biologic Products
2) By Generics: Branded Generics, Generic Small Molecules, Generic Extended-Release Formulations, Over-The-Counter (OTC) Generics
Generic Pharmaceuticals Market Industry Trends Fueling Future Revenue Growth
Leading companies within the generic pharmaceuticals market are increasingly focusing their efforts on introducing new generic drug products to maximize their market profits. The launch of generic pharmaceutical products involves making available a generic variant of a branded medication in the market. For example, in July 2023, Amneal Pharmaceuticals Inc., a publicly traded generics and specialty pharmaceutical company based in the US, introduced its authorized generic version of Xyrem 1 (Sodium Oxybate) oral solution CIII across the United States. Sodium oxybate oral solution, 0.5 g/mL, is a central nervous system depressant prescribed for narcolepsy patients aged seven years and older who experience cataplexy or excessive daytime sleepiness (EDS).
Generic Pharmaceuticals Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the generic pharmaceuticals market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals Inc., Dr. Reddy’s Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co. Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), EMS Pharma, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen
View The Full Generic Pharmaceuticals Market Report:
Generic Pharmaceuticals Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the generic pharmaceuticals market in 2025. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
